Al-Dahmani K, Mohammad S, Imran F, et al. Sellar masses: an epidemiological study. Can J Neurol Sci. 2016;43:291–7. https://doi.org/10.1017/cjn.2015.301.

Article  PubMed  Google Scholar 

Imran SA, Yip CE, Papneja N, et al. Analysis and natural history of pituitary incidentalomas. Eur J Endocrinol. 2016;175:1–9. https://doi.org/10.1530/EJE-16-0041.

Article  PubMed  CAS  Google Scholar 

Barroso-Sousa R, Barry WT, Garrido-Castro AC, et al. Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis. JAMA Oncol. 2018;4:173–82. https://doi.org/10.1001/jamaoncol.2017.3064.

Article  PubMed  Google Scholar 

Regal M, Páramo C, Sierra SM, et al. Prevalence and incidence of hypopituitarism in an adult caucasian population in northwestern Spain. Clin Endocrinol. 2001;55:735–40. https://doi.org/10.1046/j.1365-2265.2001.01406.x.

Article  CAS  Google Scholar 

Jasim S, Alahdab F, Ahmed AT, et al. Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine. 2017;56:33–42. https://doi.org/10.1007/s12020-016-1159-3.

Article  PubMed  CAS  Google Scholar 

Ehrnborg C, Hakkaart-Van Roijen L, et al. Cost of Illness in adult patients with hypopituitarism. PharmacoEconomics. 2000;17:621–8. https://doi.org/10.2165/00019053-200017060-00008.

Article  PubMed  CAS  Google Scholar 

Tiemensma J, Biermasz NR, van der Mast RC, et al. Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly. J Clin Endocrinol Metab. 2010;95:E392–402.

Article  PubMed  CAS  Google Scholar 

Pivonello R, Auriemma RS, Delli Veneri A, et al. Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study. Eur J Endocrinol. 2022;187:823–45. https://doi.org/10.1530/EJE-22-0263.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Broersen LHA, Andela CD, Dekkers OM, et al. Improvement but no normalization of quality of life and cognitive functioning after treatment of Cushing Syndrome. J Clin Endocrinol Metab. 2019;104:5325–37. https://doi.org/10.1210/jc.2019-01054.

Article  PubMed  Google Scholar 

Tiemensma J, Biermasz NR, Middelkoop HA, et al. Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing’s Disease. J Clin Endocrinol Metab. 2010;95:E129–141. https://doi.org/10.1210/jc.2010-0512.

Article  PubMed  CAS  Google Scholar 

Kars M, van der Klaauw AA, Onstein CS, et al. Quality of life is decreased in female patients treated for microprolactinoma. Eur J Endocrinol. 2007;157:133–9. https://doi.org/10.1530/EJE-07-0259.

Article  PubMed  CAS  Google Scholar 

Sievers C, Ising M, Pfister H, et al. Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls. Eur J Endocrinol. 2009;160:367–73. https://doi.org/10.1530/EJE-08-0896.

Article  PubMed  CAS  Google Scholar 

Zada G, Kintz N, Pulido M, et al. Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review. PLoS ONE. 2013;8:e76562. https://doi.org/10.1371/journal.pone.0076562.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Imran SA, Tiemensma J, Kaiser SM, et al. Morphometric changes correlate with poor psychological outcomes in patients with acromegaly. Eur J Endocrinol. 2016;174:41–50. https://doi.org/10.1530/EJE-15-0888.

Article  PubMed  CAS  Google Scholar 

Chen J, Xiang Z, Zhang Z, et al. Cognitive dysfunction, an increasingly valued long-term impairment in acromegaly. J Clin Med. 2023;12:2283. https://doi.org/10.3390/jcm12062283.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bengtsson D, Ragnarsson O, Berinder K, et al. Psychotropic Drugs in patients with Cushing’s Disease before diagnosis and at long-term follow-up: a nationwide study. J Clin Endocrinol Metab. 2021;106:1750–60. https://doi.org/10.1210/clinem/dgab079.

Article  PubMed  PubMed Central  Google Scholar 

van der Meulen M, Zamanipoor Najafabadi AH, Lobatto DJ, et al. Healthcare utilization and costs among prolactinoma patients: a cross-sectional study and analysis of determinants. Pituitary. 2021;24:79–95. https://doi.org/10.1007/s11102-020-01089-1.

Article  PubMed  Google Scholar 

Bala A, Dziedzic T, Olejnik A, et al. Attention and working memory in patients with prolactinomas: a case-control study. Sci Rep. 2022;12:22565. https://doi.org/10.1038/s41598-022-26331-7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yedinak CG, Fleseriu M. Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study. Endocrine. 2014;46:585–93. https://doi.org/10.1007/s12020-013-0106-9.

Article  PubMed  CAS  Google Scholar 

Brummelman P, Elderson MF, Dullaart RP, et al. Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clin Endocrinol. 2011;74:481–7. https://doi.org/10.1111/j.1365-2265.2010.03947.x.

Article  Google Scholar 

Fournier-Goodnight AS, Ashford JM, Merchant TE, et al. Neurocognitive functioning in pediatric craniopharyngioma: performance before treatment with proton therapy. J Neurooncol. 2017;134:97–105. https://doi.org/10.1007/s11060-017-2492-y.

Article  PubMed  PubMed Central  Google Scholar 

Aldave G, Okcu MF, Chintagumpala M, et al. Comparison of neurocognitive and quality-of-life outcomes in pediatric craniopharyngioma patients treated with partial resection and radiotherapy versus gross-total resection only. J Neurosurg Pediatr. 2023;31:453–62. https://doi.org/10.3171/2022.12.PEDS22367.

Article  PubMed  Google Scholar 

Slagboom TNA, Deijen JB, Van Bunderen CC, et al. Psychological well-being and Illness perceptions in patients with hypopituitarism. Pituitary. 2021;24:542–54. https://doi.org/10.1007/s11102-021-01131-w.

Article  PubMed  PubMed Central  Google Scholar 

Mahajan C, Prabhakar H, Bilotta F. Endocrine dysfunction after traumatic Brain Injury: an ignored clinical syndrome? Neurocrit Care. 2023. https://doi.org/10.1007/s12028-022-01672-3.

Article  PubMed  PubMed Central  Google Scholar 

Wass JA, Reddy R. Growth hormone and memory. J Endocrinol. 2010;207:125–6. https://doi.org/10.1677/JOE-10-0126.

Article  PubMed  CAS  Google Scholar 

Moreau OK, Cortet-Rudelli C, Yollin E. Growth hormone replacement therapy in patients with traumatic brain injury. J Neurotrauma. 2013;30:998–1006. https://doi.org/10.1089/neu.2012.2705.

Article  PubMed  Google Scholar 

Arwert LI, Deijen JB, Müller M, et al. Long-term growth hormone treatment preserves GH-induced memory and mood improvements: a 10-year follow-up study in GH-deficient adult men. Horm Behav. 2005;47:343–9. https://doi.org/10.1016/j.yhbeh.2004.11.015.

Article  PubMed  CAS  Google Scholar 

Blackmore DG, Waters MJ. The multiple roles of GH in neural ageing and injury. Front Neurosci. 2023;17:1082449. https://doi.org/10.3389/fnins.2023.1082449.

Article  PubMed  PubMed Central  Google Scholar 

Nyberg F, Burman P. Growth hormone and its receptors in the central nervous system - location and functional significance. Horm Res. 1996;45:18–22. https://doi.org/10.1159/000184753.

Article  PubMed  CAS  Google Scholar 

Castro JR, Costoya JA, Gallego R, et al. Expression of growth hormone receptor in the human brain. Neurosci Letts. 2000;281:147–50. https://doi.org/10.1016/s0304-3940(00)00830-2.

Article  CAS  Google Scholar 

Mercado M, Dávila N, McLeod JF, et al. Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues. J Clin Endocrinol Metab. 1994;78:731–5. https://doi.org/10.1210/jcem.78.3.8126150.

Article  PubMed  CAS  Google Scholar 

Lai Z, Emtner M, Roos P, et al. Characterization of putative growth hormone receptors in human choroid plexus. Brain Res. 1991;546:222–6. https://doi.org/10.1016/0006-8993(91)91485-j.

Article  PubMed  CAS  Google Scholar 

Lai Z, Roos P, Zhai Q, et al. Age-related reduction of human growth hormone binding sites in the human brain. Brain Res. 1993;621:260–6. https://doi.org/10.1016/0006-8993(93)90114-3.

Article  PubMed  CAS  Google Scholar 

Johansson JO, Larson G, Andersson M, et al. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinol. 1995;61:57–66. https://doi.org/10.1159/000126813.

Article  CAS